Followers of big pharma are likely to be keen to hear from GSK PLC (LSE:GSK, NYSE:GSK) and Novo Nordisk (NYSE:NVO) on Wednesday, while later on the Federal Reserve meeting will be in focus.
Analysts at UBS waxed optimistic about the UK group in the run-up to results, underpinned by projections for its Shingrix shingles vaccine, driven by a new market opportunity in China ...read more.
As for Novo, its Ozempic weight-loss drug has transformed the Danish company from an also-ran to Europe's largest drug company but other me-too rivals are waiting in the wings ...read more.
In the US, Fed head Jerome Powell will announce the central bank's latest decision, which is widely predicted to see rates left unchanged and some push-back against forecasts of a March cut ...read the macro preview.
In the news for all the wrong reasons lately, earnings from aeroplane maker Boeing Inc could be interesting. Ahead of the update, the US aviation regulator capped production of the 737 Max 9s plane following a mid-flight door blowout earlier this month ...read more.
Others due to report:
Interims: ITM Power PLC (AIM:ITM), NWF Group PLC (AIM:NWF)
Finals: Abrdn Private Equity Opportunities Trust PLC, Aberforth Smaller Companies Trust PLC
US earnings: Automatic Data Processing Inc (NASDAQ:ADP, ETR:ADP), Boeing Co (NYSE:BA, ETR:BCO), Mastercard Inc (NYSE:MA), Thermo Fisher Scientific (NYSE:TMO) Inc, Qualcomm Inc
AGMs: Imperial Brands Group, Mobile Streams, Oxford Metrics (AIM:OMG) PLC, Schroder Asia Pacific Fund, Smiths News PLC (LSE:SNWS)
Economic announcements: MBA Mortgage Applications (US), Employment Cost Index (US), Chicago PMI (US), Crude Oil Inventories (US)